Evaluate the Distribution and Dynamic Behavior of TH-SC01 Cells in Vivo in Patients With Perianal Fistula

Key facts

Sponsor

Jiangsu Topcel-KH Pharmaceutical Co., Ltd.

Intervention

Mesenchymal Stem Cells (MSCs)(biological)

Enrollment

8 enrolled

Eligibility

18-70 years · All sexes

Timeline

2024 – 2025

Study locations (1)

• The first Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

Collaborators

The First Affiliated Hospital of Soochow University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Anal fistula

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07520500
  IFOC Compared With LIFT in High Anal Fistula
  Cairo University
• RECRUITINGNCT07519850
  The Impact of Perianal Disease on Patient's Sex Life
  AHEPA University Hospital
• RECRUITINGNCT07477496
  Recurrence and Anal Fistula Patient Reported Outcomes Trial
  National and Kapodistrian University of Athens
• RECRUITINGNANCT07334678
  TROPIS Versus Coring Out Fistulectomy in High Anal Fistula
  Cairo University
• RECRUITINGNANCT07399353
  Comparative Study: Fistula Rerouting vs. LIFT for High Perianal Fistula
  Cairo University
• ENROLLING BY INVITATIONEARLY PHASE1NCT07128953
  Study on the Mechanism of Zuoqing San Promoting Postoperative Wound Healing of Anal Fistula by Inhibiting ROS-dependent NETosis
  The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
• RECRUITINGNANCT07081373
  Study on Repeat Liposomal Bupivacaine for Post-Surgery Pain in Anal Fistula Patients.
  Sixth Affiliated Hospital, Sun Yat-sen University
• RECRUITINGNCT07021742
  BioHealx® Anal Fistula Device Post Market Surveillance Study
  Signum Surgical USA Inc.

See all trials for Anal fistula →